Polifarma acquires Ketoftil's AICs
Polifarma Spa announces the purchase of the rights on Ketoftil's AICs for Italy and the World, which is already under concession from the corporation Oftagest srl.
In addition to the projects already launched in recent years in ophthalmology and other therapeutic areas of interest, this investment provides the corporation with an important positioning in the ophthalmology area and strengthens the company's list of products for a new optimistic future.
Consistently with the Acquisition strategies defined, the ownership of this asset, a market leader in its category, will result in increased margins and investment capacity for the company's development.
Share
Are you a medical specialist?
Register on the site, take advantage
of the contents and services dedicated to you!
